Meeting
2023 ASCO Annual Meeting
Comprehensive analysis of patients with cancer with a positive CHEK2 test: Are we getting closer to a genotype/phenotype correlation?
Authors
Ana Fragoso
Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisboa, Portugal
Ana Fragoso , Mafalda Melo , Teresa Neves , Sidonia Santos , Teresa Duarte , Sandra Bento , Ana Carla Luís , Isalia Miguel , Beatriz Mira , Joana Parreira , Paula Rodrigues , Inês Carvalho , Sofia Fernandes , Fatima H Vaz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Hereditary Cancer Syndromes
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10588)
DOI
10.1200/JCO.2023.41.16_suppl.10588
Abstract #
10588
Poster Bd #
221
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Women with pathogenic variants in moderate penetrance breast cancer genes: How frequently do they meet high penetrance genetic testing criteria?
First Author: Nicole Casasanta
Poster
2022 ASCO Annual Meeting
A pilot study to increase cascade genetic testing in families with hereditary cancer syndromes.
First Author: Steven J. Katz
First Author: Krystal Brown
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos